Introduction
Asthma is one of the most common multi-complex disorders triggered by the interaction of genetic predisposition and environmental factors (Cookson 2002) . Unlike other inflammatory diseases, the asthmatic inflammatory process is characterized by the predom-inant secretion of Interleukin (IL)-4 and IL-5 by Thelper lymphocyte type 2 (Th2) cells and immunoglobulin E (IgE) synthesis. IgE has been shown to mediate both early and late asthmatic responses in an induction of lung eosinophil infiltration and Th2 cell cytokine production (Coyle et al. 1996) . Mast cells are activated independent of IgE, while eosinophils and basophils are recruited into the site of the allergic reaction (Daser et al. 1995; O'Garra 1998) . The accumulation of eosinophils is an important characteristic feature in the pathogenesis of asthma because it accompanied by inflammation within the bronchial wall (Humbles et al. 1997) .
In general, naive T helper cells are differentiated into Th1 or Th2 cells depending on multiple influences by cytokines, types of antigen, transcription factors and signaling pathways (Ho and Glimcher 2002) . However, genetic polymorphisms may be one of the more crucial factors that predispose to the imbalance between Th1 and Th2 cells. Interestingly, Th1 and Th2 cells crossregulate the differentiation of partner subset, which suggests that the stimulation of Th1 cells could suppress Th2 cells and the allergic inflammation. On the other hand, the predominant induction of Th2 cells inhibits autoimmune diseases, while the induction of Th1 cells regulates the induction of asthma and allergic diseases (Hofstra et al. 1998; Lack et al. 1994) .
IL-12 is regarded as playing a central role in the early differentiation of naive T cells into those with the Th1 phenotype. Furthermore, the cytokine is a strong inducer of interferon gamma (IFN-c) production and promotes a protective cell-mediated immune response in the case of Mycobacterium tuberculosis infection (Cooper et al. 1997) . IL-27 has only recently been determined to be a novel heterodimeric cytokine of the IL-12 family. This molecule is composed of two subunits. One is a soluble type I cytokine receptor-like molecule that is coded by the Epstein-Barr virus (EBV)-induced gene 3 (EBI3); this subunit has sequence homology with IL-12p40 (Devergne et al. 1996) . The other subunit is p28 (Pflanz et al. 2002) . Structurally, the heterodimeric IL-27p28 chain belongs to the family of long-chain four-helix bundle cytokines and displays sequence homology to IL-12p35 and IL-23p19 (Pflanz et al. 2002) . EBI3 and p28 are highly co-expressed in activated tumor-suppressor gene products called adenomatous polyposis coli (APCs) (Pflanz et al. 2002; Wirtz et al. 2005) . The IL-27 receptor (IL-27R) is composed of the class I cytokine receptor chain WSX-1 (also known as TCCR) and the cytokine IL-6-related gp130 chain (Pflanz et al. 2004; Sprecher et al. 1998) . The biological effects of IL-27 are mediated by the WSX-1 that is highly expressed on CD4 + T lymphocytes and NK cells.
IL-27 is known to play multiple roles in the up-regulation of Th1 initiation as well as in the down-regulation of Th2 factor Gata binding protein 3 (GATA-3). In comparison with wild-type mice, WSX-1 (-/-) mice manifest significantly increased levels of airway immune response and serum IgE with infiltration of the pulmonary eosinophil, indicating that IL-27 and WSX-1 have a function in the down-regulation of airway hyper-reactivity and lung inflammation during the development of allergic asthma (Miyazaki et al. 2005) . The dissociated expression of EBI3 and p28 in transformed cells suggests that EBI3 may play a role -independent of its association with p28 -in the regulation of anti-viral and anti-tumoral responses (Larousserie et al. 2005) .
Although, IL-27p28 is one of the crucial candidate genes for the development and differentiation of T cells, a correlation between single nucleotide polymorphisms (SNPs) of IL-27p28 and individual susceptibility of asthma have been only poorly demonstrated. In an attempt to gain a better understanding of the genetic influences of IL-27p28 on asthma, we have identified the possible variation sites and SNPs in the five exons and their boundary intron sequences of IL-27P28 (that include the approx. 1.9-kb promoter regions). Secondly, to determine whether these IL-27P28 SNPs are associated with susceptibility to asthma, we have analyzed their frequencies on genomic DNAs isolated from asthma patients and healthy controls. Finally, we have investigated the relationships between individual asthma patients and the polymorphisms by measuring total serum IgE levels and by counting peripheral blood eosinophil numbers.
Materials and methods

Patients and DNA samples
With the approval of the review board of the School of Medicine, Wonkwang University and the informed consent of the participants in the study, we obtained blood samples from 288 asthma patients (150 males and 138 females) and 444 healthy non-asthma controls (278 males and 166 females). The mean ages of asthma patients and healthy controls were about 53 and 49 years, respectively. Genomic DNA was extracted from leukocytes of peripheral blood by a standard phenol-chloroform method or by means of a Genomic DNA Extraction kit (iNtRON Biotechnology, Korea) according to the manufacturer's directions. The asthma (atopic and non-atopic) patients were recruited from our outpatient clinic at Chonbuk National University Hospital. Asthma was diagnosed in accordance with the criteria of the American Thoracic Society (American Thoracic Society 1987). The healthy controls were recruited from the general population and had undergone a comprehensive medical screening at the Wonkwang University Hospital. All subjects employed in this study were Korean living in the same area. Blood eosinophil counts and total serum IgE levels in asthma patients were measured at the Department of Hematology of Chonbuk National University Hospital, using a Coulter GenSTM Hematology Analyzer (Florida, USA) and Roche COBAS-CORE II (Roche Diagnostics, Basal, Switzerland), respectively.
Polymerase chain reaction (PCR) and sequencing analysis
The entire coding regions of IL-27P28, including the 1.9-kb promoter regions, were partially amplified with using the GeneAmp PCR System 9700 thermocycler (PE Applied Biosystems, Foster City, Calif.) and three primer pairs (Table 1 ). The PCR was carried out in a total reaction volume of 20 ll containing 50 ng genomic DNA, 0.5 lM primers, 0.2 mM dNTP, 1.5 mM MgCl 2 , 10 mM Tris-HCl (pH 8.3) and 1 U EF Taq polymerase (Solgent, Korea). The reactions were carried out at 94°C for 5 min, followed by 30 cycles at 98°C for 10 s, at 68°C for 30 s and at 72°C for 2 min. The final extension was completed at 68°C for 7 min. After purification using a PCR purification kit (Millipore, Bedford, Mass.), the PCR products were used as a template DNA for sequencing analysis (ABI Prism BigDye Terminator cycle sequencing system; ABI 3100 automatic sequencer, PE Applied Biosystems). The sense and antisense strands of PCR products were sequenced directly. The same primers (Table 1) were used as sequencing primers. For the sequencing of the promoter region, five additional primers were employed (Table 1 ). The SNPs of IL-27P28 were detected by sequence analysis that was based on the reference sequence of human chromosome 16 clone CIT987SK-A-575C2 (AC138894; U95740).
Single-base extension (SBE)
Genotyping (for g.-964A > G, g.2905T > G and g.4730T > C in the IL-27P28 gene) was performed by SBE with ABI Prism SNaPshot Multiplex kit (Applied Biosystems). The PCR products purified using the PCR Purification kit (Millipore) were used as the template DNA for three SBE primers ( Table 1 ). The SBE reaction mix was prepared according to a previously described method (Chae et al. 2005) . The primer extension reaction was performed at 96°C for 1 min, followed by 25 cycles at 96°C for 10 s, 55°C for 40 s and 60°C for 30 s. To clean up the primer extension reaction, we added 1 U of calf intestinal alkaline phosphatase (CIP; New England BioLabs, Beverly, Mass.) to the reaction mixture and thenincubated the latter at 37°C for 60 min. The extension reaction was terminated at 72°C for 15 min. The purified extension products were added to Hi-Di formamide (Applied Biosystems) and incubated at 95°C for 5 min, followed by 5 min on ice and then electrophoresis on an ABI Prism 3100 Genetic Analyzer. ABI Prism GENESCAN and GENOTYPER software (Applied Biosystems) were used to analyze the sequencing results.
Statistic analysis
The v 2 tests were applied to estimate the HardyWeinberg equilibrium (HWE). Pair-wise comparison of biallelic loci was employed for the analyses of Linkage Disequilibrium (LD). The haplotype frequencies of IL-27P28 for multiple loci were estimated using the expectation maximization (EM) algorithm with SNPALYZE software (DYNACOM, Japan). Logistic regression analyses were adapted to calculate odds ratios (95% confidence interval). For statistic analysis, the ANOVA method was applied to define IgE levels of each genotype and to count the number of peripheral blood eosinophil from individual asthma patients. A P value of less than 0.05 was considered to indicate statistical significance.
Results
The cytokine IL-27, which is composed of two subunits, EBI3 and p28, is a novel IL-12 family member that functions in the differentiation of Th1 cells. Human IL27p28 is located on chromosome 16p11 and consists of five exons. To determine possible sites of variation in the entire coding regions and the boundary intron sequences of IL-27p28, including the approx. 1.9-kb promoter regions, we first scanned the genomic DNAs isolated from 32 unrelated controls. We identified, using a direct sequencing method, four SNPs, g.-964A > G (rs153109), g.2905T > G, g.4603G > A (rs181207) and g.4730T > C (rs181206) (Fig. 1) . The novel SNPs g.2905T > G and g.4730T > C are located on exon 2 and exon 4, respectively, and a single nucleotide transition T to G at g.2905T > G and T to C at g.4730T > C resulted in an amino acid change to p.Ser59Ala and p.Leu119Pro, respectively. LD coefficients (|D¢|) between all SNP pairs were calculated and the absolute LD (|D¢| = 1 and r 2 = 1) was found between g.4603G > A and g.4730T > C (data not shown). Among the polymorphisms identified in this study, three SNPs (g.-964A > G, g.2905T > G and g.4730T > C) were selected for large sample genotyping based on locations, LDs and frequencies.
We then analyzed the genotype of these SNPs on asthma patients and non-asthmatic controls by the SBE method. The genotype and allele frequencies were compared between these groups ( Table 2 ). The genotype frequencies of all loci were in HWE (P > 0.05, data not shown). The genotype and allele frequencies of g.2905T > G and g.4730T > C were not significantly different between asthma patients and controls. However, in asthma patients, the genotype and allele frequencies of g.-964A > G of IL-27p28 were significantly different from those of the control groups (P = 0.006 and 0.003, respectively). We further analyzed the genotype and allele frequencies of the SNPs in atopic asthma and non-atopic asthma patients and in healthy controls (Table 3 ). The genotype and allele frequencies of the g.-964A > G SNP in both atopic and nonatopic asthma patients were significantly different from those in healthy control group (genotype frequencies: P = 0.013 and 0.022, respectively; allele frequencies: P = 0.012 and 0.006, respectively).
The results of association analysis between genotypes (of individual asthma patients) indicate that these SNPs of IL-27p28 are not considerably linked with the levels of total serum IgE and with peripheral blood eosinophil count (Table 4) . In both asthma patients and controls, the haplotype frequencies of g.-964A > G, g.2905T > G and g.4730T > C of IL-27p28 were calculated and compared (Table 5) . Four major haplotypes were identified that explained more than 95.0 and 94.7% of the distribution in the controls and asthma patients, respectively, out of eight possible haplotypes. The distribution rate of the two haplotypes ATT and GGT was notably different between the asthma patients and controls (P < 0.035).
Discussion
Developing activated Th cells differentiate into phenotypically and functionally two distinct types of cells, Th1 and Th2 (Abbas et al. 1996; Mosmann and Coffman 1989) . Th1 cells produce cytokines such as interferon-c (IFN-c), IL-12 and cytotoxic factor lymphotoxin. They are commonly associated with cellmediated immune responses against intracellular pathogens and the induction of organ-specific autoimmune diseases (Abbas et al. 1996; Kuchroo et al. 1995) . On the other hand, the Th2 cell-related cytokines IL-4, IL-5 and IL-10 are known to be associated with atopic and allergic diseases. Allergic disorders are usually accompanied by increased levels of IgG1 and IgE following the activation of eosinophil and mast cells (Hofstra et al. 1998) . IL-27 (IL-12-related cytokine) is one of the critical cytokines that functions as a mediator between the innate and adaptive immune system. Macrophages and dendritic cells produce IL-27 within hours of the stimulation triggered by pathogens. The expression rate of the cytokine is an important factor in determining an effective cell-mediated immune response . IL-27 and WSX-1 play an important role in the down-regulation of airway hyper-reactivity and lung inflammation during the development of allergic asthma through their suppressive effect on cytokine production (Miyazaki et al. 2005) . Therefore, we postulated that SNPs of the IL-27 promoter region may be associated with the aggravated symptom of asthma in different individuals because of a lower production of IL-27 than necessary. In this study, we identified the SNPs in IL-27p28 and analyzed the genotype of these SNPs in asthma patients and non-asthmatic controls. The genotype and allele frequencies of the g.-964A > G SNP of IL-27p28 in asthma patients were significantly different from those in the control group (Table 2) . This result suggests that the g.-964A > G polymorphism of IL-27p28 may be associated with susceptibility to asthma. The polymorphisms within the binding site of the promoter region probably influence the expression of IL-27p28 through a reduced affinity of binding between the transcription factor and its binding site, although we cannot rule out the possibility that multiple genetic alterations also lead to the aggravation of asthma. Our results suggest that these polymorphisms are possibly correlated with susceptibility to allergic or autoimmune responses. The distribution of the haplotype ATT and GGT was significantly different between the asthma patients and healthy controls (Table 5) . It is most likely that those people with the haplotype ATT in g.-964A > G, g.2905T > G and g.4730T > C of IL27p28 are more prone to asthma than those with the other haplotype. Conversely, those people with the haplotype GGT in g.-964A > G, g.2905T > G and g.4730T > C of IL-27p28 would be more resistant to asthma.
Eosinophil is accumulated in high numbers in the lungs of asthmatic patients and is believed to be essential in phagocytosis as well as in the allergic and inflammatory reactions of asthma. Therefore, the number of accumulated eosinophils within the bronchial wall is a characteristic feature of asthma (Humbles et al. 1997) . It has been estimated that at least a dozen polymorphic genes regulate asthma by controlling the inflammatory response, IgE, cytokines and chemokines (Cookson 1999) . However, our results reveal that the polymorphisms of the IL-27p28 gene in asthma patients are not closely associated with the level of total serum IgE or with the counts of peripheral blood eosinophil (Table 4 ). The level of IgE and the accumulation of eosinophil in chronic asthma patients most likely derive from the multiple physiological alterations that eventually lead to a late stage of asthmatic symptoms. Taken as a whole, our results strongly suggest that the g.-964A > G polymorphism of IL-27p28 could be associated with a susceptibility to asthma. The overexpression of IgE and eosinophil accumulation are most likely to be late consequences of asthma development. Our analysis of IL-27p28 polymorphisms is a novel approach that may eventually provide an insight to further functional studies of IL-27p28 in association with other allergic diseases.
